 |
Prospector
Profile
2-15-005
|
| |
| North American Scientific, Inc. |
NAICS |
339100 |
| 20200 Sunburst Street
Chatsworth, CA 91311 |
Description |
Medical Equipment Mfg. |
| (818) 734-8600 |
Employees |
88 |
| http://www.nasmedical.com |
Revenue |
(mil) |
15.3200 |
| |
Income |
(mil) |
21.0000 |
| |
Assets |
(mil) |
6.1800 |
| |
Liability |
(mil) |
9.0100 |
| |
(for the year ended 2007-10-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
North American Scientific, Inc., had a net loss of $20,998,000 for the year ended October 31, 2007, as compared with the net losses of $17,130,000 and $55,513,000 during the years ended October 31, 2006 and 2005, respectively. The Company reported revenues of $15,317,000 for the year ended October 31, 2007, as compared with the revenues of $12,594,000 and $12,032,000 reported during the years ended October 31, 2006 and 2005, respectively. As a result of its recurring losses, the Company's balance sheet at October 31, 2007, showed an accumulated deficit of $148,518,000.
|
| |
|
Intellectual Property:
The Company has 10 patents as of December 31, 2007. In addition, the Company has eight additional United States pending patent applications. The Company has also been issued five foreign patents and has nine foreign patent applications still pending. The Company also licenses from third parties some of the technologies used in its core products. [SEC Filing 10-K 01-29-08]
|
| |
|
Description:
North American Scientific, Inc., designs, develops, manufactures, and sells radioisotopic products for the treatment of cancer.
|
| |
|
Officers:
John B. Rush (Pres. & CEO); Troy A. Barring (SVP & COO); L. Michael Cutrer (Chief Technology Officer); James W. Klingler (CFO)
|
| |
|
Auditor:
Singer Lewak Greenbaum & Goldstein LLP
|
| |
|
Securities:
Common Stock Symbol NASI; NasdaqCM; 92,403,471 common shares outstanding as of January 28, 2008.
|
| |
| |
| |
| return to main page |
|
|
